Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage

Green,Victoria L.; Alexandropoulou,Afroditi; Walker,Mary B.; Walker,Andrew A.; Sharp,Donald M.; Walker,Leslie G.; Greenman,John

doi:10.3892/etm_00000018

Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage

Authors:
- Victoria L. Green
- Afroditi Alexandropoulou
- Mary B. Walker
- Andrew A. Walker
- Donald M. Sharp
- Leslie G. Walker
- John Greenman
View Affiliations

Affiliations: Centre for Biomedical Research, University of Hull, Cottingham Road, Hull, HU6 7RX, UK. v.l.green@hull.ac.uk
Published online on: January 1, 2010 https://doi.org/10.3892/etm_00000018
Pages: 97-108

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The diagnosis and treatment of breast cancer can adversely affect quality of life. Here the aim was to determine the effects of reflexology on host defences and endocrine function in women with early breast cancer. Six weeks after surgery for early breast cancer, 183 women were randomly assigned to self-initiated support (SIS), SIS plus foot reflexology, or SIS plus scalp massage. Peripheral blood mononuclear cells and serum were isolated at T1 (6 weeks post surgery; baseline), T2 and T3 (4 and 10 weeks post completion of intervention, respectively). Lymphocyte phenotyping found that CD25+ cells were significantly higher in the massage group compared with the SIS group at T3. The percentage of T cells, and more specifically the T helper subset expressing IL4, decreased significantly in the massage group compared with the SIS group at T3. This change was accompanied by an increase in the percentage of CD8+ T cytotoxic cells expressing IFNγ in the massage group. Natural killer and lymphokine activated killer cell cytotoxicity measurements, serum levels of cortisol, prolactin and growth hormone, and flow cytometric assessment of their corresponding receptors all revealed no significant differences between the three groups of patients. This study provides evidence that the immunological balance of patients can be altered in a potentially beneficial manner by massage. The original trial was registered with the International Standard Randomised Controlled Trial Registry (ISRCTN87652313).

View Figures

View References

1.	Cancer Research UK: News and Resources (http://info.cancerresearchuk.org/cancerstats/types/breast/incidenceuri).
2.	Zabora J, Brintzenhofenszoc K, Curbow B, Hooker C and Piantadosi S: The prevalence of psychological distress by cancer site. Psychooncology. 10:19–28. 2001. View Article : Google Scholar : PubMed/NCBI
3.	Hall A, A’Hern R and Fallowfield L: Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer. 35:79–85. 1999. View Article : Google Scholar : PubMed/NCBI
4.	Burgess C, Cornelius V, Love S, Graham J, Richards M and Ramirez A: Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 330:7022005.PubMed/NCBI
5.	Cassileth BR and Vickers AJ: High prevalence of complementary therapy and alternative medicine use among cancer patients. J Clin Oncol. 23:2590–2592. 2005. View Article : Google Scholar : PubMed/NCBI
6.	Molassiotis A, Fernadez-Ortega P, Pud D, et al: Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 16:655–663. 2005. View Article : Google Scholar : PubMed/NCBI
7.	Ernst AR and White A: The BBC survey of complementary medicine use in the UK. Complement Ther Med. 8:32–36. 2000. View Article : Google Scholar : PubMed/NCBI
8.	Matthews AK, Sellergren MA, Huo D, List M and Fleming G: Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med. 13:555–562. 2007. View Article : Google Scholar : PubMed/NCBI
9.	Corner J, Cawley N and Hildebrand S: An evaluation of the use of massage and essential oils on the wellbeing of cancer patients. Int J Palliat Nurs. 1:67–73. 1995.
10.	Elenkov IJ and Chrousos GP: Stress system – Organization, physiology and immunoregulation. Neuroimmunomodulation. 13:257–267. 2006.
11.	Walker LG, Green VL, Greenman J, Walker A and Sharp DM: PNI and Chronic Malignant Disease: Cancer. Human Psychoneuroimmunology (PNI). Irwin M and Vedhara K: Oxford University Press; UK: pp. 137–163. 2005
12.	Herbert TB and Cohen S: Stress and immunity in humans: a meta-analytic review. Psychosom Med. 55:364–379. 1993. View Article : Google Scholar : PubMed/NCBI
13.	Segerstrom SC and Miller GE: Psychological stress and the immune system: a meta-analytic study of 30 years of enquiry. Psychol Bull. 130:601–630. 2004.PubMed/NCBI
14.	Ghiringhelli F, Menard C, Puig PE, et al: Metronomic cyclophosphamide regimen selectively depletes CD4⁺CD25⁺ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother. 56:641–648. 2007.PubMed/NCBI
15.	Spiegel D and Giese-Davis J: Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 54:269–282. 2003. View Article : Google Scholar : PubMed/NCBI
16.	Yang EV and Glaser R: Stress-induced immunomodulation: implications for tumorigenesis. Brain Behav Immun. 17(Suppl 1): 37–40. 2003. View Article : Google Scholar
17.	Penninx BW, Guralnik JM, Pahor M, Ferrucci L, Cerhan JR, Wallace RB and Havlik RJ: Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst. 90:1888–1893. 1998. View Article : Google Scholar : PubMed/NCBI
18.	Ikeda H, Old LJ and Schreiber RD: The roles of IFNγ in protection against tumour development and cancer immunoediting. Cytokine Growth Factor Rev. 13:95–109. 2002.
19.	Nelson EL, Wenzel LB, Osann K, et al: Stress, immunity and cervical cancer: biobehavioural outcomes of a randomized clinical trial. Clin Cancer Res. 14:2111–2118. 2008. View Article : Google Scholar : PubMed/NCBI
20.	Neuner A, Schindel M, Wildenberg U, Muley T, Lahm H and Fischer JR: Prognostic significance of cytokine modulation in non-small cell lung cancer. Int J Cancer. 101:2872–2892. 2002. View Article : Google Scholar
21.	O’Hara RJ, Greenman J, MacDonald AW, et al: Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res. 4:1943–1948. 1998.PubMed/NCBI
22.	Webster Marketon JI and Glaser R: Stress hormones and immune function. Cell Immunol. 252:16–26. 2008.PubMed/NCBI
23.	Lightman SL: The neuroendocrinology of stress: a never ending story. J Neuroendocrinol. 20:880–884. 2008. View Article : Google Scholar : PubMed/NCBI
24.	Dohi K, Kraemer WJ and Mastro AM: Exercise increases prolactin-receptor expression on human lymphocytes. J Appl Physiol. 94:518–524. 2003. View Article : Google Scholar : PubMed/NCBI
25.	Gotovac K, Sabioncello A, Rabatic S, Berki T and Dekaris D: Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin Exp Immunol. 131:335–339. 2003. View Article : Google Scholar
26.	Rapaport R, Sills IN, Green L, et al: Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononuclear cell subsets by flow cytometry: correlation with growth hormone-binding protein levels. J Clin Endocrinol Metab. 80:2612–2619. 1995.
27.	Malarkey WB and Mills PJ: Endocrinology: the active partner in PNI research. Brain Behav Immun. 21:161–168. 2007. View Article : Google Scholar : PubMed/NCBI
28.	Besedovsky HO and Rey AD: Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun. 21:34–44. 2007. View Article : Google Scholar : PubMed/NCBI
29.	Leonard BE: The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry. 20(Suppl 3): 302–306. 2005. View Article : Google Scholar : PubMed/NCBI
30.	Ross K: Mapping pathways from stress to cancer progression. J Natl Cancer Inst. 100:914–917. 2008. View Article : Google Scholar : PubMed/NCBI
31.	Facchinetti F, Tarabusi M and Volpe A: Cognitive-behavioral treatment decreases cardiovascular and neuroendocrine reaction to stress in women waiting for assisted reproduction. Psychoneuroendocrinology. 29:162–173. 2004. View Article : Google Scholar
32.	Gaab J, Blattler N, Menzi T, Pabst B, Stoyer S and Ehlert U: Randomized controlled evaluation of the effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects. Psychoneuroendocrinology. 28:767–779. 2003. View Article : Google Scholar : PubMed/NCBI
33.	McKinney CH, Antoni MH, Kumar M, Tims FC and McCabe PM: Effects of guided imagery and music (GIM) therapy on mood and cortisol in healthy adults. Health Psychol. 16:390–400. 1997. View Article : Google Scholar : PubMed/NCBI
34.	Cruess DG, Antoni MH, McGregor BA, et al: Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med. 62:304–308. 2000. View Article : Google Scholar
35.	Turner-Cobb JM, Sephton SE, Koopman C, Blake-Mortimer J and Spiegel D: Social support and salivary cortisol in women with metastatic breast cancer. Psychosom Med. 62:337–345. 2000. View Article : Google Scholar : PubMed/NCBI
36.	Van der Pompe G, Duivenvoorden HJ, Antoni MH, Visser A and Heijnen CJ: Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res. 42:453–466. 1997.PubMed/NCBI
37.	Heinrichs M, Baumgartner T, Kirschbaum C and Ehlert U: Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 54:1389–1398. 2003. View Article : Google Scholar : PubMed/NCBI
38.	Eremin O, Walker MB, Simpson E, et al: Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast carcinoma undergoing multimodality treatment. Breast. 18:17–25. 2008. View Article : Google Scholar
39.	Andersen BL, Farrar WB, Golden-Kreutz DM, et al: Psychological, behavioral and immune changes after a psychological intervention: a clinical trial. J Clin Oncol. 22:3570–3580. 2004. View Article : Google Scholar : PubMed/NCBI
40.	McGregor BA, Antoni MH, Boyers A, Alferi SM, Blomberg BB and Carver CS: Cognitive-behavioural stress management increases benefit finding and immune function among women with early stage breast cancer. J Psychosom Res. 56:1–8. 2004. View Article : Google Scholar
41.	Hernandez-Reif M, Ironson G, Field T, et al: Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. J Psychosom Res. 57:45–52. 2004. View Article : Google Scholar : PubMed/NCBI
42.	Walker LG, Walker MB, Ogston K, et al: The psychological, clinical and pathological effects of relaxation training and imagery during primary chemotherapy. Br J Cancer. 80:262–268. 1999. View Article : Google Scholar : PubMed/NCBI
43.	Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N and Fahey JL: A structured psychiatric intervention for cancer patients. II Changes over time in immunological measures. Arch Gen Psychiatry. 47:729–735. 1990. View Article : Google Scholar : PubMed/NCBI
44.	Walker LG: Psychosocial Oncology in Hull and the East Riding of Yorkshire. Newsletter of the British Psychosocial Oncology Society. March;10–12. 2000.
45.	Anderson BL: Psychological interventions for cancer patients to enhance quality of life. J Consult Clin Psychol. 60:552–568. 1992. View Article : Google Scholar : PubMed/NCBI
46.	Boyum A: Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran and ficoll as erythrocyte-aggregating agents. Scand J Clin Lab Invest. 97:31–50. 1968.
47.	Jung T, Schauer U, Heusser C, Neuman C and Rieger C: Detection of intracellular cytokines by flow cytometry. J Immunol Methods. 159:197–207. 1993. View Article : Google Scholar : PubMed/NCBI
48.	Piriou L, Chilmonczyk S, Genetet N and Albina E: Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry. 41:289–297. 2000. View Article : Google Scholar : PubMed/NCBI
49.	Carlens S, Gilljam M, Chambers BJ, et al: A new method for in vitro expansion of cytotoxic human CD3–CD56+ natural killer cells. Hum Immunol. 62:1092–1098. 2001.
50.	Vickers AJ and Altman DG: Statistics notes: analysing controlled trials with baseline and follow-up measurements. BMJ. 323:1123–1124. 2001. View Article : Google Scholar : PubMed/NCBI
51.	Carlson LE, Speca M, Patel KD and Goodey E: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 65:571–581. 2003. View Article : Google Scholar
52.	Wilkinson SM, Love SB, Westcombe AM, et al: Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicentre randomized controlled trial. J Clin Oncol. 25:532–539. 2007. View Article : Google Scholar : PubMed/NCBI
53.	Kuss I, Hathaway B, Ferris RL, Gooding W and Whiteside TL: Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease. Adv Otorhinolaryngol. 62:161–172. 2005.PubMed/NCBI
54.	Hong WS, Min Y, Son YS and Hong S: Peripheral blood lymphocyte subsets in patients with stomach cancer. J Korean Med Sci. 10:164–168. 1995. View Article : Google Scholar : PubMed/NCBI
55.	Heys SD, Gough DB and Eremin O: Immunotherapy with interleukin-2, recent developments. Expert Opin Investig Drugs. 5:269–288. 1996. View Article : Google Scholar
56.	Al Sarireh B and Eremin O: Tumour associated macrophage (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb. 45:1–16. 2000.PubMed/NCBI
57.	Beyer M and Schultze JL: Regulatory T cells in cancer. Blood. 108:804–811. 2006. View Article : Google Scholar : PubMed/NCBI
58.	Curiel TJ: Tregs and rethinking cancer immunotherapy. J Clin Invest. 117:1167–1174. 2007. View Article : Google Scholar : PubMed/NCBI
59.	Trzonkowski P, Szmit E, Myśliwska J and Myśliwski A: CD4⁺CD25⁺ T regulatory cells inhibit cytotoxic acitivity of CTL and NK cells in humans – impact of immunosenescence. Clin Immunol. 119:307–316. 2006.
60.	Hernandez-Reif M and Field T: Natural killer cells and lymphocytes increase in women with breast cancer following massage therapy. Int J Neurosci. 115:495–510. 2005. View Article : Google Scholar : PubMed/NCBI
61.	Bakke AC, Purtzer MZ and Newton P: The effect of hypnotic-guided imagery on psychological well-being and immune function in patients with prior breast cancer. J Psychosom Res. 53:1131–1137. 2002. View Article : Google Scholar : PubMed/NCBI
62.	Brittenden J, Heys SD, Ross J and Eremin O: Natural killer cells and cancer. Cancer. 77:1226–1243. 1996. View Article : Google Scholar : PubMed/NCBI
63.	Malmberg KJ, Bryceson YT, Carlsten M, et al: NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer Immunol Immunother. 57:1541–1552. 2008. View Article : Google Scholar : PubMed/NCBI
64.	Joshi AD, Clark EM, Wang P, et al: Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. J Neuroimmune Pharmacol. 2:202–212. 2007. View Article : Google Scholar : PubMed/NCBI
65.	Godoy-Ramirez K, Franck K and Gaines H: A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multiparameter flow cytometry. J Immunol Methods. 239:35–44. 2000. View Article : Google Scholar : PubMed/NCBI
66.	Glaser R, Maccallum RC, Laskowski BF, Malarkey WB, Sheridan JF and Kiecolt-Glaser JK: Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and ageing. J Gerontol A Biol Sci Med Sci. 56:477–482. 2001. View Article : Google Scholar : PubMed/NCBI
67.	Carlson LE, Speca M, Patel KD and Goodey E: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 29:448–474. 2004. View Article : Google Scholar
68.	Walker AA, Walker MB, Greenman J, Sharp DM and Walker LG: Does reflexology improve quality of life in women who have undergone surgery for early breast carcinoma? Psychooncology. 15:S1372006.